Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	154.75	121.5	81.45	113.02	94.9	61.06
Depreciation & Amortization	29.81	30.61	32.95	26.68	13.39	6.31
Other Operating Activities	48.77	40.67	33.26	25.29	34.37	22.74
Change in Accounts Receivable	-34.48	22.85	-132.94	-50.21	-0.4	-39.05
Change in Inventory	174.77	52.02	-195.6	-49.77	-33.56	-69.77
Change in Accounts Payable	37.16	-83.13	78.73	-23.15	-49.89	-0.62
Change in Other Net Operating Assets	4.16	173.32	-192.3	9.32	30.37	143.07
Operating Cash Flow	388.47	337.34	-291.43	49.18	85.9	117.96
Operating Cash Flow Growth	-	-	-	-42.75%	-27.18%	73.06%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-102.61	-96.85	-52.53	-35.12	-74.66	-47.27
Cash Acquisitions	-	-	-33.95	-	-	-
Divestitures	26.07	20.75	138.8	2.33	4.01	-
Investment in Securities	-	-	-290.25	-	-	-
Other Investing Activities	0.82	5.25	-33.17	-4.71	23.05	-18.59
Investing Cash Flow	-77.32	-72.38	-272.21	-37.94	-49.56	-66.32

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	-	384.11	-	-	-
Long-Term Debt Issued	-	2.38	21.91	-	-	-
Total Debt Issued	2.38	2.38	406.02	-	-	-
Short-Term Debt Repaid	-	-266.33	-	-157.41	-	-
Long-Term Debt Repaid	-	-23.58	-	-22.55	-	-
Total Debt Repaid	-136.05	-289.91	-	-179.95	-	-
Net Debt Issued (Repaid)	-133.67	-287.54	406.02	-179.95	-	-
Issuance of Common Stock	-	-	439.76	252.57	-	-
Other Financing Activities	-17.51	-28.02	-52.86	-24.53	-31.05	-17.03
Financing Cash Flow	-151.18	-315.56	792.92	48.08	-31.05	-17.03

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	159.96	-50.6	229.28	59.32	5.28	34.62

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	285.86	240.49	-343.96	14.06	11.23	70.69
Free Cash Flow Growth	-	-	-	25.14%	-84.11%	219.67%
Free Cash Flow Margin	12.13%	12.68%	-22.09%	1.04%	0.98%	7.13%
Free Cash Flow Per Share	18.36	15.43	-23.65	1.32	1.10	6.95
Levered Free Cash Flow	318.86	199.9	-394.34	-34.52	-107.44	-69.66
Unlevered Free Cash Flow	328.97	214.47	-378.76	-22.94	-89.98	-60.66

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	28.02	28.02	36.72	21.57	31.05	14.4
Cash Income Tax Paid	37.34	37.34	38.59	36.72	31.2	19.57
Change in Working Capital	181.62	165.06	-442.11	-113.81	-53.48	33.63

Data Source: S&P Global Market Intelligence Last updated: Aug 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 11, 2026

Data Sources Report a data error